Drug Interactions
Drug Interactions
批准号:
8334087
负责人:
Allan Edward Rettie
金额:
$137.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-08-01 至 2015-07-31
关键词:
AddressAmiodaroneAmprenavirAnticoagulantsAutomationBehaviorBiologicalBiological AssayBiological ModelsBlood - brain barrier anatomyBlood capillariesBudgetsCYP3A4 geneCarbamazepineCell modelChemicalsClinicalCollaborationsComplexConcept FormationCytochrome P450Cytochromes b5DataData CollectionDeuteriumDevelopmentDiltiazemDrug CombinationsDrug InteractionsDrug KineticsElementsEnzymesEventExpenditureFacultyFluoxetineFundingFutureGenesGenetic PolymorphismGenotypeGrantHepatocyteHumanHydroxylamineImageIn VitroIndividualInstitutionIonsItraconazoleKineticsLaboratoriesLiverMapsMass Spectrum AnalysisMedicineMethodologyMethodsMidazolamMolecularMonitorOralP-GlycoproteinPeptidesPerformancePharmaceutical PreparationsPharmacodynamicsPharmacy SchoolsPlasmaPlayPrincipal InvestigatorProgram Research Project GrantsProteinsPublicationsPublishingQuinidineQuinineReportingResearchResearch PersonnelResolutionResource SharingResourcesRodentRoleSamplingScanningSensitivity and SpecificityStudentsSystemTechniquesTechnologyTestingTimeTissue BankingTissue BanksTravelUniversitiesWarfarinWashingtonWaterbasecapillarycrosslinkhuman tissueimprovedin vivoinnovationinstrumentinstrumentationionizationmass spectrometermeetingsnile rednoveloperationprogramsresearch studyselected ion monitoringstable isotopetranslational studyurinary
中文摘要
这项跨学科项目包括四个高度合作的项目和三个核心要素,涉及华盛顿大学药学院和医学院五个部门的教师,并与其他两个机构合作。总的来说,它的重点是(i)了解使体外数据预测药物-药物相互作用复杂化的分子机制,以及(ii)开发方法,以便在人类暴露于体内药物的危险组合之前,从体外实验中预测此类事件。项目1将确定基因型对包括口服抗凝药物华法林在内的药物-药物相互作用的抑制和诱导程度的影响。
英文摘要
This interdisciplinary program project grant involves four highly collaborative projects and three Core elements involving faculty from five departments of the Schools of Pharmacy and Medicine of the University of Washington and collaboration with two other institutions. Collectively, it is focused (i) on understanding molecular mechanisms that complicate prediction of drug-drug interactions from in vitro data, and (ii) developing methods to allow the prediction of such events from in vitro experiments before humans are exposed to dangerous combinations of drugs in vivo. Project 1 will define the influence of genotype on the magnitude of inhibitory and inductive drug-drug interactions involving the oral anticoagulant drug, warfarin.
This information can guide management of warfarin drug interactions in carriers of common polymorphisms within genes controlling the pharmacokinetics and pharmacodynamics of the drug. Interactions involving alkylamine drugs are often complicated by time-dependent inhibition of P450s through formation of a metabolite-intermediate (Ml) complex. Project 2 is pioneering the concept that formation of secondary hydroxylamine metabolites of alkylamine drugs are the pivotal step in Ml complex formation in vitro and in vivo. Extrapolating from in vitro kinetic data to the in vivo situation is further complicated by the phenomenon of P450 allosterism. Project 3 is studying the mechanistic underpinning for activation kinetics among human P450s and will also test if such allosteric behavior occurs in vivo. Finally, Project 4 addresses the quantitative prediction of P-glycoprotein based drug-drug interactions at the human blood-brain barrier
These studies are possible because of novel and innovative imaging methodologies developed by this project that will be used combination with cell model systems and rodent studies.
期刊论文(246)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1021/bi801231m
发表时间:
2008-11-11
期刊:
BIOCHEMISTRY
影响因子:
2.9
作者:
[Mosher, Carrie M., Hummel, Matthew A., Tracy, Timothy S., Rettie, Allan E.]
通讯作者:
Rettie, Allan E.
DOI:
10.1002/chir.530020302
发表时间:
1990
期刊:
Chirality
影响因子:
2
作者:
[B. Testa;W. Trager]
通讯作者:
B. Testa;W. Trager
DOI:
10.1002/jps.10179
发表时间:
2002-09
期刊:
Journal of pharmaceutical sciences
影响因子:
3.8
作者:
[C. Yao;R. Levy]
通讯作者:
C. Yao;R. Levy
DOI:
--
发表时间:
1998-07
期刊:
Drug metabolism and disposition: the biological fate of chemicals
影响因子:
--
作者:
[S. Khojasteh-Bakht;L. Koenigs;Raimund M. Peter;William Trager;Sidney D. Nelson]
通讯作者:
S. Khojasteh-Bakht;L. Koenigs;Raimund M. Peter;William Trager;Sidney D. Nelson
First-pass midazolam metabolism catalyzed by 1alpha,25-dihydroxy vitamin D3-modified Caco-2 cell monolayers.
1α,25-二羟基维生素 D3 修饰的 Caco-2 细胞单层催化首过咪达唑仑代谢。
DOI:
--
发表时间:
1999
期刊:
The Journal of pharmacology and experimental therapeutics
影响因子:
--
作者:
[Fisher,JM, Wrighton,SA, Watkins,PB, Schmiedlin-Ren,P, Calamia,JC, Shen,DD, Kunze,KL, Thummel,KE]
通讯作者:
Thummel,KE
共 134 条
New Vistas in Vitamin K Metabolism
-
批准号:8477918
-
项目类别:
-
资助金额:$28.77万
-
财政年份:2013
-
负责人:Allan Edward Rettie
-
依托单位:
New Vistas in Vitamin K Metabolism
-
批准号:9031119
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2013
-
负责人:Allan Edward Rettie
-
依托单位:
Genotype-Dependent Drug Interactions
-
批准号:8380462
-
项目类别:
-
资助金额:$44.86万
-
财政年份:2012
-
负责人:Allan Edward Rettie
-
依托单位:
Genotype-Dependent Drug Interactions
-
批准号:8334083
-
项目类别:
-
资助金额:$36.13万
-
财政年份:2011
-
负责人:Allan Edward Rettie
-
依托单位:
Genotype-Dependent Drug Interactions
-
批准号:8118439
-
项目类别:
-
资助金额:$44.35万
-
财政年份:2010
-
负责人:Allan Edward Rettie
-
依托单位:
Drug Interactions
-
批准号:7559327
-
项目类别:
-
资助金额:$36.96万
-
财政年份:2008
-
负责人:Allan Edward Rettie
-
依托单位:
Genotype-Dependent Drug Interactions
-
批准号:7559316
-
项目类别:
-
资助金额:$52.17万
-
财政年份:2008
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:7668284
-
项目类别:
-
资助金额:$14.21万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:6875574
-
项目类别:
-
资助金额:$34.72万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:7021349
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:7216381
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:6782192
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
Pharmacogenetics of ADRs: Warfarin Toxicity
-
批准号:7531761
-
项目类别:
-
资助金额:$39.48万
-
财政年份:2004
-
负责人:Allan Edward Rettie
-
依托单位:
HUMAN CYP2C MODELS
-
批准号:6701164
-
项目类别:
-
资助金额:$24.44万
-
财政年份:2003
-
负责人:Allan Edward Rettie
-
依托单位:
CORE - DRUG INTERACTIONS
-
批准号:6701463
-
项目类别:
-
资助金额:$18.46万
-
财政年份:2003
-
负责人:Allan Edward Rettie
-
依托单位:
CORE--BIOTRANSFORMATION AND DISPOSITION
-
批准号:6577778
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2002
-
负责人:Allan Edward Rettie
-
依托单位:
CORE--BIOTRANSFORMATION AND DISPOSITION
-
批准号:6438199
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2001
-
负责人:Allan Edward Rettie
-
依托单位:
CORE--BIOTRANSFORMATION AND DISPOSITION
-
批准号:6495688
-
项目类别:
-
资助金额:$7.35万
-
财政年份:2001
-
负责人:Allan Edward Rettie
-
依托单位:
CORE--BIOTRANSFORMATION AND DISPOSITION
-
批准号:6301468
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2000
-
负责人:Allan Edward Rettie
-
依托单位:
CORE--BIOTRANSFORMATION AND DISPOSITION
-
批准号:6412953
-
项目类别:
-
资助金额:$11.79万
-
财政年份:2000
-
负责人:Allan Edward Rettie
-
依托单位:
海外基金